Product Description: Nanaomycin A is the first selective DNMT3B inhibitor with an IC50 of 500 nM. Nanaomycin A, a quinone antibiotics, reactivates silenced tumor suppressor genes in human cancer cells[1]. Nanaomycin A inhibits in vitro growth of the human malaria parasite Plasmodium falciparum with an IC80 value of 33.1 nM[2].
Applications: Cancer-programmed cell death
Formula: C16H14O6
References: [1]Kuck D, et al.Nanaomycin A selectively inhibits DNMT3B and reactivates silenced tumor suppressor genes in human cancer cells.Mol Cancer Ther. 2010 Nov;9(11):3015-23./[2]Tanaka Y, et al.Heme-dependent radical generation: possible involvement in antimalarial action of non-peroxide microbial metabolites, nanaomycin A and radicicol.J Antibiot (Tokyo). 1999 Oct;52(10):880-8.
CAS Number: 52934-83-5
Molecular Weight: 302.28
Compound Purity: 98.18
Research Area: Cancer; Infection
Solubility: 10 mM in DMSO
Target: Antibiotic;DNA Methyltransferase;Parasite
Deutsch
English
